David also advises publicly listed and private companies on acquisitions, dispositions, mergers and joint ventures in a wide range of industries and his experience includes cross-border transactions involving companies and shareholders across Europe and the United States, as well as China and the Middle East and North Africa.

In addition, David also represents issuers, directors, officers and employees in enforcement actions by the French securities regulator (AMF).

Show Less

• Advised Genkyotex (Biotech, France, Euronext Paris and Brussels) on a capital increase with preferential subscription rights (2021)
• Advised Invest Securities (In Flight Entertainment Technology, US, OTCQX, Euronext Paris) on an international private placement of new shares of Aerkomm, Inc. (In Flight Entertainment Technology, Etats-Unis, OTCQX, Euronext Paris) (2021)
• Advised Genkyotex (Biotech, France, Euronext Paris and Brussels) on a rights issues and on the mandatory tender offer in cash and CVRs by Calliditas Therapeutics (Stockholm and Nasdaq) (2021)
• Advised Aerkomm, Inc. (In Flight Entertainment Technology, US, OTCQX) on the initial listing of its shares on Euronext Paris*
• Advised Fosun Tourism Group (which owns Club Med) on its IPO and listing on the Main board of the Hong Kong Stock Exchange*
• Advised GeNeuro (Switzerland, Euronext Paris) on a corporate credit line granted by GNEH (Institut Mérieux)*
• Advised Genkyotex (Biotechnology, France, Euronext Paris) on two issuances of convertible bonds with warrants attached (OCABSA)*
• Advised Dietswell (Oil and Gaz exploration services, France, Euronext Growth) on its private placement of new shares*
• Advised Midcap and Oddo BHF, as underwriters, on the public offering of Wallix (Cyber, France, Euronext Paris)*
• Advised Gilbert Dupont and NIBC, as underwriters, on the IPO of Advicenne (Biotech, France) on Euronext Paris*
• Advised Symetis (Medical Device, Switzerland) and the underwriters (Bryan Garnier, Mirabaud and Baader), on Symetis’ proposed IPO and listing on Euronext Paris (which ended with Symetis acquisition by Boston Scientific)*
• Advised GenKyotex (Biotech, Switzerland) on its reverse acquisition of Genticel (Euronext Paris and Brussels) by way of a contribution in kind remunerated in newly issued Genticel shares listed on Euronext Paris and Brussels*
• Advised GeNeuro (Biotech, Switzerland) and the underwriters (Société Générale and Bryan Garnier) on GeNeuro’s IPO on Euronext Paris*
• Advised Kempen, as underwriter, on the issuance and international private placement of Nanobiotix’ (Biotech, France, Euronext Paris) shares*
• Advised a French provider of serialization software solutions on its proposed IPO and listing on Euronext Paris (postponed after filing with the AMF)*
• Advised Société Générale and Kempen, as underwriters, on the IPO and dual listing of Mainstay Medical (Medical Device, Ireland) on Euronext Paris and the Irish Stock Exchange*
• Advised Eren Group on the IPO of Orège (Cleantech, France) on Euronext Paris*
• Advised L’Occitane (Cosmetics, Luxembourg/France) on its IPO on the Hong Kong Stock Exchange*
• Advised the underwriters on the IPO of Helikos (SPAAC of Wendel) on Deutsche Börse*
• Advised Heidelberg Cement (Germany) on the “re-IPO” international offering of 35% of the shares of Vicat (Cement, France, Euronext Paris) held by Heidelberg Cement*
• Advised UBS and Merrill Lynch, as underwriters on the projected IPO of HBM Bioventures (Life Science investment, Switzerland) on SWX (postponed after filing with the securities regulator)*
• Advised Merrill Lynch and Natixis, as underwriters, on Novagali Pharma’s (Biotech, France) IPO project on Euronext Paris (postponed after initial filing with the AMF)*
• Advised Doughty Hanson (Private Equity fund) on its projected IPO on Euronext Amsterdam (postponed after initial filing with Dutch AFM)*
• Advised LCF Edmond de Rothschild (Banking and asset management, France) on its projected IPO on Euronext Paris (postponed after initial filing with the AMF)*
• Advised Morgan Stanley and Calyon, as underwriters, on the projected IPO of Resico (Gecina’s residential real estate spin-off, France) on Euronext Paris (postponed after initial filing with the AMF)*
• Advised ING and Bryan Garnier, as underwriters, on the IPO of Bioalliance Pharma (Biotech, France) on Euronext Paris*
• Advised Wendel, as main shareholder, on the IPO of Legrand (Electrical infrastructures) on Euronext Paris*
• Advised Saft (Batteries, France) on its IPO on Euronext Paris*
• Advised Iliad (Holding company of Free, Telecom, France) on its IPO on Euronext Paris*
• Advised UBS, acting as underwriter on IDM’s (Biotech, France) projected IPO on Euronext Paris (postponed after initial filing with the AMF)*
• Advised the underwriters on Air France-KLM (Airline, France, Euronext Paris) on its privatization and international secondary offering of shares*
• Advised Morgan Stanley, BNPP, JP Morgan, SG, ABN Amor Rothschild and Merrill Lynch, as underwriters on the privatization and international secondary share offering of France Telecom (Telecom, France, Euronext Paris)*
• Advised HSBC, Lehman Brothers and Société Générale, as underwriters, on the privatization and IPO of Autoroutes Paris-Rhin-Rhône (Toll road operator, France) on Euronext Paris*
• Advised Société Générale and CSFB, as underwriters, on the privatization and international secondary share offering of Dassault Systèmes (Software, France, Euronext Paris)*
• Advised HSBC and Credit Lyonnais, as underwriters, on the privatization and IPO of Autoroutes du Sud de la France (Toll road operator, France)*
• Advised ABN-AMRO Rothschild, JPMorgan, BNP and Credit Agricole Indosuez, as underwriters on Bacou-Dalloz’ (Protection Gear, France) “re-IPO” rights issue*
• Advised Société Générale and Cazenove, acting as underwriters, Memscap’s (MEMS Technology, France) IPO and listing on Euronext Paris*
• Advised as underwriters on EADS NV (Aerospace, The Netherlands) IPO and listing on Euronext Paris, Madrid Stock Exchange and Euronext Paris*
• Advised Aerospatiale Matra (Aerospace, France) on its privatization and IPO (Euronext Paris)*
• Advised Riber (Semiconductor equipment, France) on its IPO and listing on Euronext Paris*
• Advised Bank Hapoalim (Banking, Israel) on its IPO and international offering (London Stock Exchange)*

Other Securities Offerings (equity secondary offerings, rights issues, private placements, PIPEs, convertible bonds)

• Advised on behalf of issuers or underwriters on equity and equity-linked securities offerings of Erytech, Pixium, GeNeuro, Genkyotex, Dietswell, Wallix, LBC Terminals, Orchestra, Soitec, Ingenico, Alcatel-Lucent, Saft, Cegedim, SIICParis, Imerys, Hammerson, Faiveley, Steria, Cesar, Rhodia, Société de la Tour Eiffel, France Telecom, Studio Canal, Medidep, Havas Advertising, Orchestra-Kazibao, and Lafarge*

Mergers and acquisitions

• Advised Pharnext (Biotech, France, Euronext Growth) on the issuance of bonds and warrants to Néovacs (Biotech, France Euronext Growth) and the renegotiation of its OCEANE-BSA and Loan Agreement with GTO 13 (Alpha Blue Ocean) (2022)
• Advised Pharnext (Biotech, France, Euronext Growth) on its financing by ABO (GTO13) (2022)
• Advised Genkyotex (France, Euronext Paris and Brussels) on the mandatory tender offer and subsequent squeeze-out and delisting offer in cash and CVRs by Calliditas Therapeutics (Sweden, Stockholm and Nasdaq)
• Advised PFH, sole shareholder of the Bansard International group (transport & logistics, France), on the sale of the Bansard International group to SEKO Logistics (Transport & logistics, United States)
• Advised the shareholders of Récupération Valorisation Aluminium (RVA) (Auminium salt slag recycling, France) on the sale of RVA to Real Alloy (Aluminium recycling, United States)
• Advised Alcatel (Technology, France, Euronext Paris) on its USD 13.5 billion merger with Lucent Technologies (Technology, United States, NYSE)*
• Advised Fonds Stratégique d’Investissement (France) on its PIPE in Cegedim (Healthcare digital data services, France, Euronext Paris)*
• Advised Ubisoft (Gaming, France, Euronext Paris) on various M&A and corporate governance matter*
• Advised Compagnie Financière Edmond de Rothschild (Banking and asset management, France) on its strategic partnership with Bank of China and Bank of China’s proposed 20% minority investment in LCFR*
• Advised Carlson Wagonlit Travel (Professional Travel, France) on the creation of a common network with Groupe Nouvelles Frontières under the brand Havas Voyages*
• Advised General Dynamics, Inc. (Aerospace and Defense, U.S., NYSE) on its acquisition of the French operations of Axletech Inc*
• Advised Genkyotex (Biotech, Switzerland) on its reverse acquisition of Genticel (Biotech, Euronext Paris and Brussels)*
• Advised KWS SAAT (Plant breeding, Germany, Börse Frankfurt) on its acquisition of French company Momont, and the creation of Gemstar, a French joint venture with Vilmorin (Euronext Paris)*
• Advised Qualcomm (Nasdaq) on its strategic alliance with Alcatel-Lucent (Technology, Euronext Paris) and its acquisition of up to four tranches of existing Alcatel-Lucent treasury shares*
• Advised Faurecia (Automotive, France, Euronext Paris) on the acquisition of Sora Composites and on the acquisitions of selected operations of Borgers and Mecaplast*
• Advised SIIC de Paris (Real Estate, France, Euronext Paris) and its Spanish shareholder Realia on the 30% contribution by Société Foncière Lyonnaise (Real Estate, Euronext Paris) in SIIC de Paris*
• Advised GE Real Estate (Real Estate, France) on its buy-out tender offer on IPBM (REIT, Euronext Paris)*
• Advised Eren Group (Investment fund, France) in relation to its acquisition of a 25% stake in Orege (Euronext Paris) in connection with its IPO*
• Advised Alcatel-Lucent (Technology, France, Euronext Paris) on the restructuring of NextiraOne*
• Advised Holmarcom (Investment company, Morocco) on the Joint Venture of Regional Airlines with Air Arabia (Air Arabia Maroc)*

*Matter handled prior to joining McDermott

Show Less